Hiroki Mukai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiroki Mukai has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Hajime Yokota
Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
9 shared publications - Takashi Uno
Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
7 shared publications - Satoshi Kuwabara
Department of Neurology, Graduate School of Medicine, Chiba University, Japan
3 shared publications Takashi Uno
Radiology, Chiba University Graduate School of Medicine, Chiba, JPN
3 shared publications- Takuro Horikoshi
Diagnostic Radiology and Radiation Oncology Chiba University Graduate School of Medicine Chiba Japan
3 shared publications - Atsuhiko Sugiyama
Department of Neurology, Graduate School of Medicine, Chiba University, Japan
2 shared publications
Latest Publications
- 1 November 2026
- Published by SAGE Publications in Canadian Association of Radiologists Journal
Suspected Myelitis on MRI: Narrowing the Differential Diagnosis and Deciding What to Check Next
Intramedullary T2 hyperintensity on spinal magnetic resonance imaging is not specific for myelitis; infarction, compression, venous congestion, tumor, and nutritional deficiency produce the same finding. Nearly half of the patients referred for transverse myelitis have a non-inflammatory cause, and compressive myelopathy and spinal arteriovenous fistula are often misdiagnosed as inflammatory or neoplastic disease, delaying treatment by months. Because the tests that establish a specific cause cannot be performed exhaustively and take time, the initial scan usually sets the direction of the work-up. This review shows radiologists reading a “suspected myelitis” scan what to consider first and what to ask the clinician to confirm or refute that suspicion. Two axes organize the assessment: the time from symptom onset to nadir, and the lesion distribution on sagittal, axial, and contrast-enhanced images. Eight imaging patterns defined by these axes are each linked to the first diagnosis to consider and to the single piece of information that changes the decision. A distinctive feature is the handling of numbers: published sensitivities and specificities in spinal cord disease mostly derive from small studies with restricted populations and comparators, and exceptions are common, so each number is presented with the population and comparator in which it was obtained and is used only within that range. The normal-appearing scan, discordance between antibody or rapid polymerase chain reaction results and imaging, and techniques that secure decision-changing images are also addressed. The report should state what the imaging supports, what cannot be excluded, and what to check next.
- 1 November 2026
- Published by SAGE Publications in Canadian Association of Radiologists Journal
Suspected Myelitis on MRI: Narrowing the Differential Diagnosis and Deciding What to Check Next
Intramedullary T2 hyperintensity on spinal magnetic resonance imaging is not specific for myelitis; infarction, compression, venous congestion, tumor, and nutritional deficiency produce the same finding. Nearly half of the patients referred for transverse myelitis have a non-inflammatory cause, and compressive myelopathy and spinal arteriovenous fistula are often misdiagnosed as inflammatory or neoplastic disease, delaying treatment by months. Because the tests that establish a specific cause cannot be performed exhaustively and take time, the initial scan usually sets the direction of the work-up. This review shows radiologists reading a “suspected myelitis” scan what to consider first and what to ask the clinician to confirm or refute that suspicion. Two axes organize the assessment: the time from symptom onset to nadir, and the lesion distribution on sagittal, axial, and contrast-enhanced images. Eight imaging patterns defined by these axes are each linked to the first diagnosis to consider and to the single piece of information that changes the decision. A distinctive feature is the handling of numbers: published sensitivities and specificities in spinal cord disease mostly derive from small studies with restricted populations and comparators, and exceptions are common, so each number is presented with the population and comparator in which it was obtained and is used only within that range. The normal-appearing scan, discordance between antibody or rapid polymerase chain reaction results and imaging, and techniques that secure decision-changing images are also addressed. The report should state what the imaging supports, what cannot be excluded, and what to check next.
- 8 October 2026
- Published by Springer Nature in Neuroradiology
- p. 1-8
Normal asymmetric superior ophthalmic vein dilatation: morphological features and differentiation from carotid cavernous fistula
Purpose Asymmetry of the superior ophthalmic vein (SOV) is occasionally encountered on routine imaging and may reflect either pathology or normal variation. This study aimed to characterize normal asymmetric SOV dilatation and differentiate it from pathological dilatation due to carotid cavernous fistula (CCF). Methods We retrospectively measured SOV diameters at the distal, middle, and proximal levels on three-dimensional time-of-flight magnetic resonance angiography in 200 patients without abnormal intracranial findings and 30 patients with CCF. Significant asymmetry was defined as a side-to-side diameter difference of >0.5 mm at one or more levels. SOV hyperintensity was also assessed. Morphological features were compared between normal asymmetric and CCF-related pathological SOV dilatation. Results Significant SOV asymmetry was observed in 31 of 200 patients (15.5%) without abnormal intracranial findings. Pathological dilatation showed significantly larger SOV diameters at all three levels than normal asymmetric dilatation. SOV hyperintensity was more frequent in pathological dilatation than in normal asymmetric dilatation (21/30 [70.0%] vs. 8/31 [25.8%], P < 0.001). Normal asymmetric SOV dilatation was more prominent at the distal and middle levels and showed relative tapering at the proximal level. For identifying normal asymmetric SOV dilatation, the middle-to-proximal ratio showed moderate discriminatory performance (area under the curve, 0.791; 95% confidence interval, 0.675–0.907; cutoff, >1.139; sensitivity, 93.5%; specificity, 63.3%). Conclusion Proximal tapering of a dilated SOV may be a morphological feature of normal asymmetric dilatation and may serve as an adjunctive imaging clue for differentiation from CCF-related pathological dilatation.
- 8 October 2026
- Published by Springer Nature in Neuroradiology
- p. 1-8
Normal asymmetric superior ophthalmic vein dilatation: morphological features and differentiation from carotid cavernous fistula
Purpose Asymmetry of the superior ophthalmic vein (SOV) is occasionally encountered on routine imaging and may reflect either pathology or normal variation. This study aimed to characterize normal asymmetric SOV dilatation and differentiate it from pathological dilatation due to carotid cavernous fistula (CCF). Methods We retrospectively measured SOV diameters at the distal, middle, and proximal levels on three-dimensional time-of-flight magnetic resonance angiography in 200 patients without abnormal intracranial findings and 30 patients with CCF. Significant asymmetry was defined as a side-to-side diameter difference of >0.5 mm at one or more levels. SOV hyperintensity was also assessed. Morphological features were compared between normal asymmetric and CCF-related pathological SOV dilatation. Results Significant SOV asymmetry was observed in 31 of 200 patients (15.5%) without abnormal intracranial findings. Pathological dilatation showed significantly larger SOV diameters at all three levels than normal asymmetric dilatation. SOV hyperintensity was more frequent in pathological dilatation than in normal asymmetric dilatation (21/30 [70.0%] vs. 8/31 [25.8%], P < 0.001). Normal asymmetric SOV dilatation was more prominent at the distal and middle levels and showed relative tapering at the proximal level. For identifying normal asymmetric SOV dilatation, the middle-to-proximal ratio showed moderate discriminatory performance (area under the curve, 0.791; 95% confidence interval, 0.675–0.907; cutoff, >1.139; sensitivity, 93.5%; specificity, 63.3%). Conclusion Proximal tapering of a dilated SOV may be a morphological feature of normal asymmetric dilatation and may serve as an adjunctive imaging clue for differentiation from CCF-related pathological dilatation.
- 6 December 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 127, 110589
Coronary artery black-blood imaging via T2-prepared phase-sensitive inversion-recovery steady-state free precession in Kawasaki disease
- 6 December 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 127, 110589
Coronary artery black-blood imaging via T2-prepared phase-sensitive inversion-recovery steady-state free precession in Kawasaki disease
- Open Access
- 16 April 2025
- Published by Springer Nature in Cureus
- Vol. 17 (4)
Post-thalamotomy Changes Mimicking Cavernous Malformations on MRI: A Case Report of a Historical Surgical Treatment
The patient was a 65-year-old man with cervical dystonia onset at age six who had been treated at Chiba University Hospital. He was diagnosed and followed up with cavernous malformations and chronic cerebral infarctions based on an MRI. However, during the re-evaluation of MRI, lesions with low signal intensity (SI) cores surrounded by high SI rims were observed in bilateral thalami and left subthalamic nucleus on T2-weighted images, which differed from typical cavernous malformations. In addition, symmetrical scarring changes were noted in the frontal lobes and bilateral parietal bones, potentially corresponding to the thalamic and subthalamic nucleus lesions. Upon reviewing medical history, it was revealed that the patient had undergone thalamotomy in 1963 and 1964. The literature review suggested the use of procaine-oil blocking during thalamotomies of that era. Chemical shift imaging was added, and the presence of fat was confirmed in bilateral thalamic lesions with high SI on in-phase and low SI on out-of-phase images. Imaging findings resulting from obsolete treatments can be unfamiliar and mistaken for pathological conditions. Investigating the history of suspected treatments can lead to definitive diagnoses through imaging studies.
- 16 April 2025
- Published by Springer Nature in Cureus
- Vol. 17 (4)
Open AccessPost-thalamotomy Changes Mimicking Cavernous Malformations on MRI: A Case Report of a Historical Surgical Treatment
The patient was a 65-year-old man with cervical dystonia onset at age six who had been treated at Chiba University Hospital. He was diagnosed and followed up with cavernous malformations and chronic cerebral infarctions based on an MRI. However, during the re-evaluation of MRI, lesions with low signal intensity (SI) cores surrounded by high SI rims were observed in bilateral thalami and left subthalamic nucleus on T2-weighted images, which differed from typical cavernous malformations. In addition, symmetrical scarring changes were noted in the frontal lobes and bilateral parietal bones, potentially corresponding to the thalamic and subthalamic nucleus lesions. Upon reviewing medical history, it was revealed that the patient had undergone thalamotomy in 1963 and 1964. The literature review suggested the use of procaine-oil blocking during thalamotomies of that era. Chemical shift imaging was added, and the presence of fat was confirmed in bilateral thalamic lesions with high SI on in-phase and low SI on out-of-phase images. Imaging findings resulting from obsolete treatments can be unfamiliar and mistaken for pathological conditions. Investigating the history of suspected treatments can lead to definitive diagnoses through imaging studies.
- Open Access
- 28 March 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022, 1-7
DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson’s Disease: Voxel-Based Morphometry
Taq1A polymorphism is a DRD2 gene variant located in an exon of the ANKK1 gene and has an important role in the brain’s dopaminergic functions. Some studies have indicated that A1 carriers have an increased risk of developing Parkinson’s disease (PD) and show poorer clinical performance than A2 homo carriers. Previous studies have suggested that A1 carriers had fewer dopamine D2 receptors in the caudate and increased cortical activity as a compensatory mechanism. However, there is little information about morphological changes associated with this polymorphism in patients with PD. The study’s aim was to investigate the relationship between brain volume and Taq1A polymorphism in PD using voxel-based morphometry (VBM). Based on Taq1A polymorphism, 103 patients with PD were divided into two groups: A1 carriers (A1/A1 and A1/A2) and A2 homo carriers (A2/A2). The volume of the left prefrontal cortex (PFC) was significantly decreased in A2 homo carriers compared to A1 carriers. This finding supports the association between Taq1A polymorphism and brain volume in PD and may explain the compensation of cortical function in A1 carriers with PD.
- 28 March 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022, 1-7
Open AccessDRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson’s Disease: Voxel-Based Morphometry
Taq1A polymorphism is a DRD2 gene variant located in an exon of the ANKK1 gene and has an important role in the brain’s dopaminergic functions. Some studies have indicated that A1 carriers have an increased risk of developing Parkinson’s disease (PD) and show poorer clinical performance than A2 homo carriers. Previous studies have suggested that A1 carriers had fewer dopamine D2 receptors in the caudate and increased cortical activity as a compensatory mechanism. However, there is little information about morphological changes associated with this polymorphism in patients with PD. The study’s aim was to investigate the relationship between brain volume and Taq1A polymorphism in PD using voxel-based morphometry (VBM). Based on Taq1A polymorphism, 103 patients with PD were divided into two groups: A1 carriers (A1/A1 and A1/A2) and A2 homo carriers (A2/A2). The volume of the left prefrontal cortex (PFC) was significantly decreased in A2 homo carriers compared to A1 carriers. This finding supports the association between Taq1A polymorphism and brain volume in PD and may explain the compensation of cortical function in A1 carriers with PD.
- Open Access
- 15 February 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (1) , 82-87
Frontotemporal Brain Sagging Syndrome as a Treatable Cause Mimicking Frontotemporal Dementia: A Case Report
Frontotemporal brain sagging syndrome (FBSS) is a progressive disorder characterized by symptoms similar to the behavioral variant of frontotemporal dementia (FTD), with a sagging appearance of the brain on imaging similar to that observed in spontaneous intracranial hypotension (SIH). The onset of behavioral and cognitive symptoms of FBSS is insidious and progressive, similar to those of FTD. Here, we report a case involving a 53-year-old man with progressive hypersomnolence, apathy, forgetfulness, and personality changes but without headache or auditory symptoms. The combination of frontotemporal dysfunction, hypersomnolence, and the appearance of a sagging brain on magnetic resonance imaging suggested a diagnosis of FBSS. Although a definite site of cerebrospinal fluid leakage could not be identified in our case, clinical symptoms and imaging findings were improved after an epidural blood patch. Considering FBSS as a differential diagnosis of FTD is important even in the absence of typical SIH symptoms, such as headache or auditory symptoms.
- 15 February 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (1) , 82-87
Open AccessFrontotemporal Brain Sagging Syndrome as a Treatable Cause Mimicking Frontotemporal Dementia: A Case Report
Frontotemporal brain sagging syndrome (FBSS) is a progressive disorder characterized by symptoms similar to the behavioral variant of frontotemporal dementia (FTD), with a sagging appearance of the brain on imaging similar to that observed in spontaneous intracranial hypotension (SIH). The onset of behavioral and cognitive symptoms of FBSS is insidious and progressive, similar to those of FTD. Here, we report a case involving a 53-year-old man with progressive hypersomnolence, apathy, forgetfulness, and personality changes but without headache or auditory symptoms. The combination of frontotemporal dysfunction, hypersomnolence, and the appearance of a sagging brain on magnetic resonance imaging suggested a diagnosis of FBSS. Although a definite site of cerebrospinal fluid leakage could not be identified in our case, clinical symptoms and imaging findings were improved after an epidural blood patch. Considering FBSS as a differential diagnosis of FTD is important even in the absence of typical SIH symptoms, such as headache or auditory symptoms.
- Open Access
- 16 December 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (3) , 544-548
Band-like hyperintensity along the ventral surface of the brain stem on FLAIR and DWI in leptomeningeal carcinomatosis of lung adenocarcinoma
- 16 December 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (3) , 544-548
Open AccessBand-like hyperintensity along the ventral surface of the brain stem on FLAIR and DWI in leptomeningeal carcinomatosis of lung adenocarcinoma
- 28 September 2021
- Published by S. Karger AG in European Neurology
- Vol. 85 (2) , 95-103
Nerve Hypertrophy and Altered Diffusion in Anti-Myelin-Associated Glycoprotein Neuropathy Detected by Brachial Plexus Magnetic Resonance Neurography
Introduction: This study assessed the morphological changes and diffusion tensor imaging (DTI)-derived parameters of the brachial plexus using magnetic resonance neurography (MRN) in patients with anti-myelin-associated glycoprotein (anti-MAG) neuropathy. Methods: Eight patients with anti-MAG neuropathy underwent MRN of the brachial plexus with 3-dimensional (3D) short tau inversion recovery (STIR) and DTI sequences. Two neuroradiologists and a neurologist qualitatively assessed nerve hypertrophy on 3D STIR MRN. The cross-sectional area (CSA) of the nerve roots was measured. Quantitative analyses of fractional anisotropy (FA) and axial, radial, and mean diffusivity (AD, RD, and MD) were obtained after postprocessing on DTI and manual segmentation. Results: There was nerve hypertrophy in 37.5% of the patients with anti-MAG neuropathy. All patients with anti-MAG neuropathy with nerve hypertrophy were refractory to rituximab therapy. The CSA of the nerve roots was inversely correlated with FA and positively correlated with MD and RD. FA decreased in the nerve roots and inversely correlated with disease duration. Conclusions: Nerve hypertrophy appears in the proximal portion of peripheral nerves, such as the brachial plexus, in patients with anti-MAG neuropathy. Altered diffusion in the nerve roots might be associated with the loss of myelin integrity due to the demyelination process in anti-MAG neuropathy.
- 28 September 2021
- Published by S. Karger AG in European Neurology
- Vol. 85 (2) , 95-103
Nerve Hypertrophy and Altered Diffusion in Anti-Myelin-Associated Glycoprotein Neuropathy Detected by Brachial Plexus Magnetic Resonance Neurography
Introduction: This study assessed the morphological changes and diffusion tensor imaging (DTI)-derived parameters of the brachial plexus using magnetic resonance neurography (MRN) in patients with anti-myelin-associated glycoprotein (anti-MAG) neuropathy. Methods: Eight patients with anti-MAG neuropathy underwent MRN of the brachial plexus with 3-dimensional (3D) short tau inversion recovery (STIR) and DTI sequences. Two neuroradiologists and a neurologist qualitatively assessed nerve hypertrophy on 3D STIR MRN. The cross-sectional area (CSA) of the nerve roots was measured. Quantitative analyses of fractional anisotropy (FA) and axial, radial, and mean diffusivity (AD, RD, and MD) were obtained after postprocessing on DTI and manual segmentation. Results: There was nerve hypertrophy in 37.5% of the patients with anti-MAG neuropathy. All patients with anti-MAG neuropathy with nerve hypertrophy were refractory to rituximab therapy. The CSA of the nerve roots was inversely correlated with FA and positively correlated with MD and RD. FA decreased in the nerve roots and inversely correlated with disease duration. Conclusions: Nerve hypertrophy appears in the proximal portion of peripheral nerves, such as the brachial plexus, in patients with anti-MAG neuropathy. Altered diffusion in the nerve roots might be associated with the loss of myelin integrity due to the demyelination process in anti-MAG neuropathy.
- Open Access
- 9 July 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-10
Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case
Background: Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. Pathologically, it is characterized by eosinophilic hyaline intranuclear inclusions in the cells of the visceral organs as well as central, peripheral, and autonomic nervous system cells. Recently, a GGC repeat expansion in the NOTCH2NLC gene has been identified as the etiopathological agent of NIID. Interestingly, this GGC repeat expansion was also reported in some patients with a clinical diagnosis of amyotrophic lateral sclerosis (ALS). However, there are no autopsy-confirmed cases of concurrent NIID and ALS. Case presentation: A 60-year-old Taiwanese woman reported a four-month history of progressive weakness beginning in the right foot that spread to all four extremities. She was diagnosed with ALS because she met the revised El Escorial diagnostic criteria for definite ALS with upper and lower motor neuron involvement in the cervical, thoracic, and lumbosacral regions. She died of respiratory failure at 22 months from ALS onset, at the age of 62 years. Brain magnetic resonance imaging (MRI) revealed lesions in the medial part of the cerebellar hemisphere, right beside the vermis (paravermal lesions). The subclinical neuropathy, indicated by a nerve conduction study (NCS), prompted a potential diagnosis of NIID. Antemortem skin biopsy and autopsy confirmed the coexistence of pathology consistent with both ALS and NIID. We observed neither eccentric distribution of p62-positive intranuclear inclusions in the areas with abundant large motor neurons nor cytopathological coexistence of ALS and NIID pathology in motor neurons. This finding suggested that ALS and NIID developed independently in this patient. Conclusions: We describe a case of concurrent NIID and ALS discovered during an autopsy. Abnormal brain MRI findings, including paravermal lesions, could indicate the coexistence of NIID even in patients with ALS showing characteristic clinical phenotypes.
- 9 July 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-10
Open AccessCoexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case
Background: Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. Pathologically, it is characterized by eosinophilic hyaline intranuclear inclusions in the cells of the visceral organs as well as central, peripheral, and autonomic nervous system cells. Recently, a GGC repeat expansion in the NOTCH2NLC gene has been identified as the etiopathological agent of NIID. Interestingly, this GGC repeat expansion was also reported in some patients with a clinical diagnosis of amyotrophic lateral sclerosis (ALS). However, there are no autopsy-confirmed cases of concurrent NIID and ALS. Case presentation: A 60-year-old Taiwanese woman reported a four-month history of progressive weakness beginning in the right foot that spread to all four extremities. She was diagnosed with ALS because she met the revised El Escorial diagnostic criteria for definite ALS with upper and lower motor neuron involvement in the cervical, thoracic, and lumbosacral regions. She died of respiratory failure at 22 months from ALS onset, at the age of 62 years. Brain magnetic resonance imaging (MRI) revealed lesions in the medial part of the cerebellar hemisphere, right beside the vermis (paravermal lesions). The subclinical neuropathy, indicated by a nerve conduction study (NCS), prompted a potential diagnosis of NIID. Antemortem skin biopsy and autopsy confirmed the coexistence of pathology consistent with both ALS and NIID. We observed neither eccentric distribution of p62-positive intranuclear inclusions in the areas with abundant large motor neurons nor cytopathological coexistence of ALS and NIID pathology in motor neurons. This finding suggested that ALS and NIID developed independently in this patient. Conclusions: We describe a case of concurrent NIID and ALS discovered during an autopsy. Abnormal brain MRI findings, including paravermal lesions, could indicate the coexistence of NIID even in patients with ALS showing characteristic clinical phenotypes.
- Open Access
- 1 July 2021
- Published by Elsevier in Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology
- Vol. 25, 42-46
Randomized comparative study of suspension femoral fixation device in graft position maintenance in anterior cruciate ligament reconstruction: EndoButton CL vs TightRope RT
- 1 July 2021
- Published by Elsevier in Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology
- Vol. 25, 42-46
Open AccessRandomized comparative study of suspension femoral fixation device in graft position maintenance in anterior cruciate ligament reconstruction: EndoButton CL vs TightRope RT